Strategies and Solutions for Early Phase Formulation Development and CTM Manufacturing

In this webinar, we discuss the strategies to overcome challenges during formulation development, various technologies available for formulation development, and Frontage CMC's unique capabilities.

"*" indicates required fields

First Name*

Last Name*

Company*

State*

Country

Email*

Phone*

Please only hit the submit button once.

I AGREE*

By submitting this form I agree that Frontage may process my data in the manner described in Frontage’s Privacy Policy.

Phone

This field is for validation purposes and should be left unchanged.

Strategies and Solutions for Early Phase Formulation Development and CTM Manufacturing

Resources to Consider

Nonclinical Vehicle Formulations:HP-β-CD...

Evaluating the feasibility of lyophilization for oral formulation...

Development of Stable Nanoemulsion Formulation as an Ophthalmic Drug...

Clinical Study of Abuse-Deterrent Formulation to Suppress Release of...

WebninarAnalytical Challenges for CMC Development of Cell and Gene...

Qualification of the Quanterix Phospho-Tau 217 (pTau-217) assay using...

Companion Diagnostics for Alzheimer’s Disease

Development and validation of an LC-MS/MS method for the...

A Competitive Ligand-binding Assay for the Detection of Neutralizing...

Validation of a 384 gene hybridization capture-based pharmacogenomics...

Immunoassays for Drug Discovery

Testing of Carryover & After MRD Benchtop Stability for...